Skip to content
Saturday, May 31, 2025
Latest:
  • Renewing hope: A global push to improve neonatal outcomes
  • FROM THE LABS: Cell Painting identifies flavonoids that are toxic to bladder cancer cells
  • Menopause 101
  • New technique offers lasting relief for slipping rib syndrome
  • Ready for space travel? GENESTAR can track how space affects your health
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
patient-friend-photo
From The Labs

Long-term survival supports the potential benefit of CAR T cell therapy to treat solid tumors

February 27, 2025 CAR T cell therapy,  Clinical Trials,  disease free,  longest survival,  neuroblastoma,  Research,  solid tumors

An 18-year survivor of neuroblastoma is believed to represent the longest reported remission to date in a patient treated with chimeric antigen receptor (CAR) T cell therapy.

Read More
From The Labs

Sprinter and marathoner CAR T cells reveal their distinct cancer-killing behavior

February 4, 2025 cancer treatment,  CAR T cell,  Research,  solid tumors

The study lays a foundation for designing CAR molecules that maximize antitumor activity beyond B cell malignancies.

Read More
Pre- and post-infusion three-dimensional imaging shows that infused GPC3 CAR T cells induce significant antitumor responses in patients.
From The Labs

From bench to bedside and back: CAR T cells armed with IL-15 show promise in treating solid cancers

January 28, 2025 cancer treatment,  CAR T cells,  Clinical Trials,  IL-15,  Research,  solid tumors

Researchers relate their journey to finding a promising method to address CAR T cell challenges in treating solid tumors.

Read More
From The Labs

CAR NKT cells, a promising step forward in the treatment of solid tumors

November 10, 2020 CAR NK T cells,  clinical trial,  Immunotherapy,  neuroblastoma,  Research,  solid tumors

An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.

Read More
From The Labs

Special delivery of IL-7 signaling makes all the difference for CAR T cells fighting solid tumors

May 15, 2018 brain tumor,  CAR T cells,  IL7,  Immunotherapy,  Research,  solid tumors

Since he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951